DK1586314T3 - Nateglinide tablet sammensætning - Google Patents

Nateglinide tablet sammensætning

Info

Publication number
DK1586314T3
DK1586314T3 DK05014497.1T DK05014497T DK1586314T3 DK 1586314 T3 DK1586314 T3 DK 1586314T3 DK 05014497 T DK05014497 T DK 05014497T DK 1586314 T3 DK1586314 T3 DK 1586314T3
Authority
DK
Denmark
Prior art keywords
tablet composition
meals
carboxymethyl cellulose
nateglinide tablet
nateglinide
Prior art date
Application number
DK05014497.1T
Other languages
English (en)
Inventor
Akira Yabuki
Masato Kaida
Takahiko Ando
Nobutaka Ninomiya
Masanao Ozaki
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18100283&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1586314(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Application granted granted Critical
Publication of DK1586314T3 publication Critical patent/DK1586314T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
DK05014497.1T 1996-11-15 1997-11-14 Nateglinide tablet sammensætning DK1586314T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31854196 1996-11-15
EP97912459A EP0965339B1 (en) 1996-11-15 1997-11-14 Tabletted nateglinide preparation

Publications (1)

Publication Number Publication Date
DK1586314T3 true DK1586314T3 (da) 2011-06-20

Family

ID=18100283

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05014497.1T DK1586314T3 (da) 1996-11-15 1997-11-14 Nateglinide tablet sammensætning

Country Status (14)

Country Link
US (4) US6143323A (da)
EP (3) EP0965339B1 (da)
JP (1) JP4171091B2 (da)
KR (1) KR100343062B1 (da)
CN (1) CN1245158C (da)
AT (2) ATE503472T1 (da)
AU (1) AU718350B2 (da)
CA (1) CA2271865C (da)
DE (2) DE69740161D1 (da)
DK (1) DK1586314T3 (da)
ES (2) ES2364145T3 (da)
PT (2) PT1586314E (da)
TW (1) TW492878B (da)
WO (1) WO1998022105A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2364145T3 (es) * 1996-11-15 2011-08-25 Ajinomoto Co., Inc. Composición de nateglinida en comprimidos.
DK1736144T3 (da) 1998-05-18 2015-12-07 Takeda Pharmaceutical Oralt disintegrerende tabletter.
ES2237121T3 (es) * 1998-07-28 2005-07-16 Takeda Pharmaceutical Company Limited Preparacion solida disgregable rapidamente.
JP2000119160A (ja) * 1998-10-06 2000-04-25 Kanebo Ltd 皮膚化粧料
US6559188B1 (en) 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
US6878749B2 (en) 1999-09-17 2005-04-12 Novartis Ag Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
AR028299A1 (es) * 1999-09-17 2003-05-07 Novartis Ag Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
ES2248159T3 (es) * 1999-12-28 2006-03-16 Ajinomoto Co., Inc. Preparaciones orales para diabetes.
PL357719A1 (en) * 2000-03-17 2004-07-26 Ajinomoto Co, Inc. Drugs for complications of diabetes and neuropathy and utilization thereof
DK1334962T3 (da) 2000-10-18 2007-12-10 Ajinomoto Kk Fremgangsmåder til fremstilling af acylphenylalanin
AU2001294265A1 (en) * 2000-10-18 2002-04-29 Ajinomoto Co., Inc. Process for producing nateglinide crystal
BR0114846A (pt) * 2000-10-24 2004-02-25 Ajinomoto Kk Método para produzir cristais de tipo b de nateglinida substancialmente livres de cristais de tipo h
TWI289461B (en) * 2000-10-24 2007-11-11 Ajinomoto Kk Nateglinide-containing hydrophilic drug preparations
CA2426263C (en) 2000-10-24 2010-05-25 Ajinomoto Co., Inc. Nateglinide-containing preparation
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
JP2003252749A (ja) * 2002-03-04 2003-09-10 Shin Etsu Chem Co Ltd 外用基剤
US6830759B2 (en) 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
CN1247194C (zh) * 2002-08-27 2006-03-29 石药集团中奇制药技术（石家庄）有限公司 一种那格列奈包合物
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
WO2005013964A1 (ja) * 2003-08-08 2005-02-17 Ajinomoto Co., Inc. ナテグリニド含有製剤
WO2005016315A1 (en) * 2003-08-14 2005-02-24 Ranbaxy Laboratories Limited Pharmaceutical compositions of nateglinide and a high amount of a water-soluble filler
KR20120064735A (ko) * 2004-04-01 2012-06-19 아지노모토 가부시키가이샤 나테글리니드 함유 제제
WO2005117840A1 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Stable pharmaceutical compositions comprising pulverized granules of nateglinide of form b
WO2006013444A1 (en) * 2004-07-28 2006-02-09 Ranbaxy Laboratories Limited Preparations of stable pharmaceutical compositions of nateglinide and processes for their preparation
US20060034927A1 (en) * 2004-08-04 2006-02-16 Gemma Casadevall Means of delivering drugs in an ascending zero order release pattern
CN101031322A (zh) * 2004-10-01 2007-09-05 日本脏器制药株式会社 固体药物制剂
US7276198B2 (en) * 2004-12-28 2007-10-02 The Goodyear Tire & Rubber Company Method and mold for making tire with tie bar
WO2006080524A1 (ja) * 2005-01-31 2006-08-03 Ajinomoto Co., Inc. 血糖降下剤を含有する、耐糖能異常、境界型糖尿病、インスリン抵抗性及び高インスリン血症の改善ないし治療用医薬組成物
US9034860B2 (en) 2006-12-07 2015-05-19 Daiichi Sankyo Company, Limited Pharmaceutical composition containing low-substituted hydroxypropyl cellulose
CA2672154C (en) * 2006-12-07 2014-11-18 Daiichi Sankyo Company, Limited Pharmaceutical composition having improved storage stability
TWI428151B (zh) * 2006-12-07 2014-03-01 Daiichi Sankyo Co Ltd 含有甘露醇或乳糖之固形製劑
KR101503083B1 (ko) * 2006-12-07 2015-03-16 다이이찌 산쿄 가부시키가이샤 고형 제제의 제조 방법
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
JP3586471B2 (ja) * 1991-06-25 2004-11-10 三菱ウェルファーマ株式会社 トラセミド含有医薬組成物
JP2508949B2 (ja) 1991-07-30 1996-06-19 味の素株式会社 Ｎ−（トランス−４−イソプロピルシクロヘキシルカルボニル）−ｄ−フェニルアラニンの結晶及びその製造法
CA2123677A1 (en) * 1991-11-26 1993-06-10 Issac Ghebre-Sellassie Process and composition for the development of controlled release gemfibrozil dosage form
ES2364145T3 (es) * 1996-11-15 2011-08-25 Ajinomoto Co., Inc. Composición de nateglinida en comprimidos.

Also Published As

Publication number Publication date
EP1586314B1 (en) 2011-03-30
US20030147951A1 (en) 2003-08-07
AU718350B2 (en) 2000-04-13
JP4171091B2 (ja) 2008-10-22
CN1245158C (zh) 2006-03-15
ATE322260T1 (de) 2006-04-15
CN1242704A (zh) 2000-01-26
ES2364145T3 (es) 2011-08-25
US6143323A (en) 2000-11-07
PT965339E (pt) 2006-06-30
US20020028239A1 (en) 2002-03-07
EP2277517A1 (en) 2011-01-26
CA2271865C (en) 2003-10-14
EP0965339A1 (en) 1999-12-22
ATE503472T1 (de) 2011-04-15
US6296872B1 (en) 2001-10-02
EP1586314A1 (en) 2005-10-19
US6844008B2 (en) 2005-01-18
EP0965339A4 (en) 2003-04-23
JPH10194969A (ja) 1998-07-28
DE69735644T2 (de) 2007-05-03
CA2271865A1 (en) 1998-05-28
KR20000053312A (ko) 2000-08-25
DE69740161D1 (de) 2011-05-12
US6641841B2 (en) 2003-11-04
AU4965497A (en) 1998-06-10
ES2257772T3 (es) 2006-08-01
KR100343062B1 (ko) 2002-07-02
EP0965339B1 (en) 2006-04-05
PT1586314E (pt) 2011-07-01
WO1998022105A1 (fr) 1998-05-28
TW492878B (en) 2002-07-01
DE69735644D1 (de) 2006-05-18

Similar Documents

Publication Publication Date Title
DK1586314T3 (da) Nateglinide tablet sammensætning
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
MX9605940A (es) Compuestos bioaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
BR0109336A (pt) Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
ES2123903T3 (es) Composicion nutritiva conteniendo fibra.
MY118164A (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
DK420385A (da) Antioestrogent laegemiddel til perkutan indgift
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
AU3284984A (en) Pharmaceutical compositions for the transdermal application of active ingredients
BR0016801A (pt) Preparação antidiabética para administração oral
DE68903988T2 (de) Acetylcystein enthaltende mundloesliche arzneimittel.
MX9100246A (es) Preparacion farmaceutica en forma de tabletas o grageas que contienen sulcralfato y procedimiento para su preparacion
CO5160272A1 (es) Combinacion de cerivastatina y fibratos
IS2234B (is) Samsetning til að bæla fráhvarfseinkenni og fíkn í áfengi hjá áfengissjúklingum og fyrirbyggja misnotkun áfengis hjá heilbrigðum einstaklingum
EP1108429A3 (en) An improved amino acid composition for providing an amino acid supplement or protein substitute, particularly for the treatment and/or management of certain diseases
CN1109357A (zh) 一种美容保健制品及工艺方法
ATE203903T1 (de) Delta-aminolävulinsäure enthaltendes arzneimittel
ES283591Y (es) Una tableta de dosificacion farmaceutica adecuada para administracion oral
RU94030887A (ru) N-ацетил-дегидрофенилаланил-l-метионин
KR970058708A (ko) 엘-무스콘(l-muscone)의 의약용도
KR910015294A (ko) 약제 조성물
LT2000063A (en) Food additive
TH26907A (th) องค์ประกอบทางเภสัชภัณฑ์ที่คงตัว
TH22534B (th) องค์ประกอบทางเภสัชภัณฑ์ที่คงตัว
KR890014121A (ko) 사람의 골공증(骨孔症) 치료를 위한 방법과 조성물